Drug Shortage Report for ODAN-SODIUM POLYSTYRENE SULFONATE
Report ID | 242931 |
Drug Identification Number | 02473968 |
Brand name | ODAN-SODIUM POLYSTYRENE SULFONATE |
Common or Proper name | Odan-Sodium Polystyrene Sulfonate Suspension 250mg/mL (500mL) |
Company Name | ODAN LABORATORIES LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
Strength(s) | 250MG |
Dosage form(s) | SUSPENSION |
Route of administration | RECTAL ORAL RECTAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 500mL |
ATC code | V03AE |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-11-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | [email protected] Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-11-14 | French | Compare |
v2 | 2024-11-14 | English | Compare |
v1 | 2024-11-14 | English | Compare |
Showing 1 to 3 of 3